Metin Kurtoglu, Chief Technology Officer at Cartesian Therapeutics, Inc. (RNAC), sold 71,478 shares at $16.67 ($1.2M) on 2024-11-21, disclosed to the SEC on 2024-11-21.
Open-market sale of $1.2M RNAC by Chief Technology Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.50 | 200 | $4K | 0.3% |
| 2 | $17.28 | 5,600 | $97K | 8.1% |
| 3 | $18.09 | 100 | $2K | 0.2% |
| 4 | $16.67 | 32,789 | $547K | 45.7% |
| 5 | $16.67 | 32,789 | $547K | 45.7% |
| Total | $16.73 avg | 71,478 |
| $1.2M |
| 100% |
| Filing → |
| RNAC | SELL | 2024-11-18 | $2.8M | — | Filing → |